Literature DB >> 10540199

Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat.

F G Brown1, D J Nikolic-Paterson, C Metz, R Bucala, R C Atkins, H Y Lan.   

Abstract

Recent studies have identified a key role for macrophage migration inhibitory factor (MIF) in a number of immune cell-mediated diseases. The current study investigated the potential role of MIF in acute allograft rejection. Lewis rats underwent bilateral nephrectomy and then received an orthotopic DA renal allograft or an orthotopic Lewis renal isograft. Groups of six animals were killed at day 1 or 5 after transplantation. No immunosuppression was used. Animals receiving a renal allograft exhibited severe rejection on day 5, as shown by high levels of serum creatinine, very low rates of creatinine clearance, and severe tubulitis with a dense macrophage and T cell infiltrate. In contrast, isografts had normal renal function on day 5 with no histological evidence of rejection. Northern blotting showed that renal MIF mRNA expression was unchanged at day 1, but was increased 3.5-fold on day 5. In situ hybridization showed a marked increase in MIF mRNA expression by tubular cells and MIF mRNA expression by many infiltrating mononuclear cells in day 5 allografts. Immunostaining confirmed an increase in tubular MIF protein expression, particularly in areas of severe tubular damage with prominent leucocytic infiltration. Double staining showed that many infiltrating macrophages and T cells expressed the MIF protein in day 5 allografts. There was only a minor increase in MIF expression in day 5 isografts, demonstrating that neither surgical injury nor stress cause significant up-regulation of MIF expression in allograft rejection. In conclusion, this study has demonstrated that local MIF production is specifically increased in acute renal allograft rejection. These results suggest that MIF may play an important role in the cellular immune response mediating acute allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540199      PMCID: PMC1905421          DOI: 10.1046/j.1365-2249.1999.01048.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

2.  A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.

Authors:  H Y Lan; W Mu; D J Nikolic-Paterson; R C Atkins
Journal:  J Histochem Cytochem       Date:  1995-01       Impact factor: 2.479

3.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT14.

Authors:  M J Bogman; I M Dooper; J G van de Winkel; W J Tax; A J Hoitsma; K J Assmann; D J Ruiter; R A Koene
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

5.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.

Authors:  N Yang; D J Nikolic-Paterson; Y Y Ng; W Mu; C Metz; M Bacher; A Meinhardt; R Bucala; R C Atkins; H Y Lan
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

7.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

8.  Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system.

Authors:  W W Hancock; D Gee; P De Moerloose; F R Rickles; V A Ewan; R C Atkins
Journal:  Transplantation       Date:  1985-04       Impact factor: 4.939

9.  A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.

Authors:  T Hünig; H J Wallny; J K Hartley; A Lawetzky; G Tiefenthaler
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  8 in total

1.  Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.

Authors:  Yi Ren; Simon Law; Xin Huang; Ping Yin Lee; Michael Bacher; Gopesh Srivastava; John Wong
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

2.  Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Authors:  Ying-Ying Wang; Hong Jiang; Jun Pan; Xiao-Ru Huang; Yu-Cheng Wang; Hong-Feng Huang; Ka-Fai To; David J Nikolic-Paterson; Hui-Yao Lan; Jiang-Hua Chen
Journal:  J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 10.121

Review 3.  Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation.

Authors:  Yao-Zhong Kong; Qiyan Chen; Hui-Yao Lan
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 4.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 5.  The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.

Authors:  C Toso; J A Emamaullee; S Merani; A M J Shapiro
Journal:  Diabetologia       Date:  2008-07-09       Impact factor: 10.122

6.  Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.

Authors:  Chao Zhang; Ting Liang; Jing Song; Shiqin Jiang; Lili Qu; Guihua Hou
Journal:  Scand J Gastroenterol       Date:  2011-03-28       Impact factor: 2.423

7.  Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.

Authors:  Jin H Li; Ying Tang; Jun Lv; Xiao H Wang; Hui Yang; Patrick M K Tang; Xiao R Huang; Zhi J He; Zi J Zhou; Qiu Y Huang; Jörg Klug; Andreas Meinhardt; Günter Fingerle-Rowson; An P Xu; Zhi H Zheng; Hui Yao Lan
Journal:  J Cell Mol Med       Date:  2019-04-09       Impact factor: 5.310

Review 8.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.